Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.09%
1,105.33
-1.03
-0.09%
1,106.361,105.681,109.291,105.29
SIXC
Communications
SIXC
Communications
SIXC
+0.59%
613.89
+3.60
+0.59%
610.29610.29613.91610.29
SIXE
Energy
SIXE
Energy
SIXE
+0.02%
1,211.51
+0.29
+0.02%
1,211.221,211.011,212.241,209.79
SIXI
Industrials
SIXI
Industrials
SIXI
+0.24%
1,754.88
+4.17
+0.24%
1,750.711,753.101,757.861,753.10
SIXM
Financials
SIXM
Financials
SIXM
+0.87%
633.62
+5.45
+0.87%
628.17629.38633.75629.38
SIXR
Staples
SIXR
Staples
SIXR
+0.34%
857.49
+2.92
+0.34%
854.57855.71857.79855.71
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.34%
217.60
+0.73
+0.34%
216.87216.87217.75216.87
SIXT
Technology
SIXT
Technology
SIXT
+0.16%
3,567.62
+4.89
+0.16%
3,561.943,571.443,574.033,562.15
SIXU
Utilities
SIXU
Utilities
SIXU
+0.10%
904.23
+0.94
+0.10%
903.31903.26904.33903.26
SIXV
Health care
SIXV
Health care
SIXV
+0.08%
1,482.76
+1.22
+0.08%
1,481.541,482.481,483.831,482.26
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.47%
2,411.32
+11.37
+0.47%
2,399.952,404.452,412.722,404.45
SLNO:NASDAQ
Soleno Therapeutics Inc
$52.98
+0.06%
(+0.030) 1D
May 14, 9:44:09 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SLNO...
Open
$52.97
High
$52.98
Low
$52.96
Mkt. cap
2.76B
Avg. vol.
5.29M
Volume
35.19K
P/E ratio
31.28
52-wk high
$90.32
52-wk low
$29.47
EPS
$1.69
Beta
-2.22
Shares outstanding
52.12M
No. of employees
182
News stories
From sources across the web
About Soleno Therapeutics Inc
CEO-
Employees182
Founded1999
HeadquartersRedwood City, California, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
32.66M
66.02M
91.73M
94.60M
Cost of goods sold
696.00K
1.14M
863.00K
1.20M
Cost of revenue
696.00K
1.14M
863.00K
1.20M
Research and development expenses
9.15M
8.40M
9.56M
11.27M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
28.24M
33.75M
40.88M
50.37M
Operating expense
37.38M
42.16M
50.44M
61.64M
Total operating expenses
38.08M
43.30M
51.30M
62.84M
Operating income
-5.42M
22.72M
40.43M
31.76M
Other non operating income
-
-
-
-
EBT including unusual items
-4.71M
26.01M
43.36M
34.91M
EBT excluding unusual items
-3.61M
26.63M
44.21M
35.40M
Income tax expense
-
-
-
3.54M
Effective tax rate
-
-
-
10.13%
Other operating expenses
-
-
-
-
Net income
-4.71M
26.01M
43.36M
31.38M
Net profit margin
-14.42%
39.40%
47.27%
33.17%
Earnings per share
-
-
-
-
Interest and investment income
3.19M
5.30M
5.13M
4.93M
Interest expense
-1.38M
-1.39M
-1.35M
-1.29M
Net interest expenses
1.82M
3.91M
3.78M
3.64M
Depreciation and amortization charges
-
-
-
-
EBITDA
-4.92M
23.22M
40.94M
32.28M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more